General Biotech

General Biotechnologies identifies and develops undervalued discoveries in the life sciences.

[General Biotech @GeneralBiotech]

https://t.co/2dyg4eneYd

[General Biotech @GeneralBiotech]

The General Biotechnologies Mission: https://t.co/aQj14l2Akk

[General Biotech @GeneralBiotech]

Accepted to #MassChallenge!

[General Biotech @GeneralBiotech]

General Biotechnologies took 1st place in the 27-team Challenge Round at the 2017 Rice Business Plan Competition! @RBPC

[General Biotech @GeneralBiotech]

General Biotechnologies will be competing in the Harvard-MIT Roivant Pitch Competition.

[General Biotech @GeneralBiotech]

General Biotechnologies will be competing in Houston next month as a finalist in the Rice Business Plan Competition! @GeneralBiotech @RBPC

[General Biotech @GeneralBiotech]

Excited to announce the completion of the first round of preclinical experiments for our lead program Nivien. @GeneralBiotech

[General Biotech @GeneralBiotech]

@cmiller1225 The intersection of biotechnology and computer science. —GB

[General Biotech @GeneralBiotech]

@tzack16 Thanks for asking, but we won't be public for some time! —GB

[General Biotech @GeneralBiotech]

AngelList: https://t.co/ah1tswdDIO
LinkedIn: https://t.co/MrS5MryL75
Crunchbase: https://t.co/lNYybL3DlH

[General Biotech @GeneralBiotech]

Our first project, Nivien, is a preclinical oncology startup with a patent-protected chemosensitizer for the treatment of pancreatic cancer.

[General Biotech @GeneralBiotech]

General Biotechnologies is a holding company to identify and develop undervalued discoveries in the life sciences. @GeneralBiotech